BNP Paribas Asset Management
ONCE

BNP Paribas Asset Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

BNP Paribas Asset Management’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-29,196
Closed -$1.32M – 1089
2015
Q4 		$1.32M Sell
29,196
-608
-2% -$31.9K 0.01% 745
2015
Q3 		$1.24M Buy
+29,804
New +$1.56M 0.01% 778

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

BNP Paribas Asset Management's ONCE Position: Q1 2016 in Review

BNP Paribas Asset Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q1 2016, closing a stake of 29,196 shares — an estimated $1.32M sold.

BNP Paribas Asset Management first reported a position in ONCE in Q3 2015 and held it in 2 quarters. The position peaked at $1.32M in Q4 2015. 105 funds tracked by Wall St. Rank hold ONCE as of Q1 2016.

  • BNP Paribas Asset Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • BNP Paribas Asset Management sold 29,196 Spark Therapeutics, Inc. Common Stock shares in Q1 2016, an estimated $1.32M.
  • BNP Paribas Asset Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2015 and held it in 2 quarters.
  • BNP Paribas Asset Management's Spark Therapeutics, Inc. Common Stock position peaked at $1.32M in Q4 2015.
  • 105 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q1 2016.

Based on BNP Paribas Asset Management's 13F filing for Q1 2016, filed 16 May 2016.